NEUROLOGY

Feb 20, 2019

Trine Apostolaki‐Hansson et al compared 90-day survival and functional outcome following non-Vitamin K Antagonist oral anticoagulants (NOAC)-intracerebral hemorrhage (ICH), the most serious…

Feb 19, 2019

The fourth annual Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2019 will take place February 28 - March 2 at the Hilton Anatole in Dallas, Texas. Themed “…

Feb 19, 2019

The XEN1101 Phase 2 clinical trial is a randomized, double-blind, placebo-controlled study that will evaluate the clinical efficacy, safety, and tolerability of increasing doses of XEN1101…

Feb 18, 2019

A 71-year-old patient was presented with sudden quadriplegia secondary to cervical (C2 to T1) epidural hematoma as a result of undiagnosed autoimmune acquired hemophilia A. She underwent emergency…

Feb 15, 2019

Watch Dr. Ulas Cikla, M.D., Dr. Kutluay Uluc, M.D., and Dr. Mustafa K. Baskaya, M.D. from the Department of Neurological Surgery, University of Wisconsin, Madison, Wisconsin present a 66-year-old…

Feb 15, 2019

Watch Dr. Ulas Cikla, M.D., Dr. Kutluay Uluc, M.D., and Dr. Mustafa K. Baskaya, M.D. from the Department of Neurological Surgery, University of Wisconsin, Madison, Wisconsin present a 66-year-old…

Feb 14, 2019

The insulin-sensitizing agent pioglitazone (Actos) appeared effective for secondary prevention in stroke patients with prediabetes, according to a post hoc analysis of the IRIS randomized clinical…

Feb 13, 2019

Bo‐Lin Ho et al assessed the safety and persistence of dabigatran after co-medication with statins. Participants in the study were stroke patients with nonvalvular atrial fibrillation (NVAF) who…